Adenoviral vaccine targeting multiple neoantigens as strategy to eradicate large tumors combined with checkpoint blockade
Vaccination against neo-antigens has resulted in an effective antitumor response in several models. Here, the authors show that delivery of larger sets of neo-antigens using an adenovirus-based vaccination platform, results in much better tumor protection when combined with checkpoint blockade in a...
Enregistré dans:
Auteurs principaux: | Anna Morena D’Alise, Guido Leoni, Gabriella Cotugno, Fulvia Troise, Francesca Langone, Imma Fichera, Maria De Lucia, Lidia Avalle, Rosa Vitale, Adriano Leuzzi, Veronica Bignone, Elena Di Matteo, Fabio Giovanni Tucci, Valeria Poli, Armin Lahm, Maria Teresa Catanese, Antonella Folgori, Stefano Colloca, Alfredo Nicosia, Elisa Scarselli |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2019
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/db93e80d193c417e9e00b2880fe30cbc |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Novel Human Anti-PD-L1 mAbs Inhibit Immune-Independent Tumor Cell Growth and PD-L1 Associated Intracellular Signalling
par: Margherita Passariello, et autres
Publié: (2019) -
Management of Adenoviral Keratoconjunctivitis: Challenges and Solutions
par: Labib BA, et autres
Publié: (2020) -
EPIDEMIOLOGY OF ADENOVIRAL INFECTION IN ST. PETERSBURG
par: I. V. Ovsyannikova, et autres
Publié: (2018) -
Neoantigens elicit T cell responses in breast cancer
par: Takafumi Morisaki, et autres
Publié: (2021) -
Protein citrullination as a source of cancer neoantigens
par: Makoto Kobayashi, et autres
Publié: (2021)